Hepatitis C remains the main etiology of hepatocellular carcinoma among liver transplant recipients in the United States in the direct-acting antiviral era

被引：0
|
作者：
Saberi, B. [1 ]
Hashim, D. [1 ]
Dinani, A. [1 ]
Asgharpour, A. [1 ]
Kushner, T. [1 ]
Tabrizian, P. [1 ]
Schwartz, M. [1 ]
Dieterich, D. [1 ]
Llovet, J. M. [1 ]
Boffetta, P. [1 ]
Friedman, S. L. [1 ]
Gurakar, A. [2 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA
[2] Johns Hopkins Comprehens Transplant Ctr, Baltimore, MD USA
来源：
TRANSPLANTATION | 2019年 / 103卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P-438
引用
收藏
页码：312 / 312
页数：1
相关论文
共 50 条
  • [21] Liver transplantation for hepatitis C virus in the era of direct-acting antiviral agents
    Audrey, Coilly
    Raffaele, Bruno
    CURRENT OPINION IN HIV AND AIDS, 2015, 10 (05) : 361 - 368
  • [22] The Impact of Direct-acting Antiviral Therapy for Hepatitis C on Hepatocellular Carcinoma Risk
    Feng Su
    George N. Ioannou
    Current Hepatology Reports, 2018, 17 (4) : 377 - 384
  • [23] Reduction in Racial and Ethnic Disparity in Survival Following Liver Transplant for Hepatocellular Carcinoma in the Direct-acting Antiviral Era
    Shaikh, Anjiya
    Goli, Karthik
    Lee, Tzu-Hao
    Rich, Nicole E.
    Benhammou, Jihane N.
    Keeling, Stephanie
    Kim, Donghee
    Ahmed, Aijaz
    Goss, John
    Rana, Abbas
    Singal, Amit G.
    Kanwal, Fasiha
    Cholankeril, George
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (09) : 2288 - 2297
  • [24] Successful Treatment of Hepatitis C in Renal Transplant Recipients With Direct-Acting Antiviral Agents
    Sawinski, D.
    Kaur, N.
    Ajeti, A.
    Trofe-Clark, J.
    Lim, M.
    Bleicher, M.
    Goral, S.
    Forde, K. A.
    Bloom, R. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (05) : 1588 - 1595
  • [25] Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals
    Cieciura, Tomasz
    Urbanowicz, Arkadiusz
    Foroncewicz, Bartosz
    Hryniewiecka, Ewa
    Paczek, Leszek
    Ciszek, Michal
    TRANSPLANTATION PROCEEDINGS, 2020, 52 (08) : 2450 - 2453
  • [26] In the Era of Direct-Acting Antivirals, Liver Transplant Delisting Due to Clinical Improvement for Hepatitis C Remains Infrequent
    Bittermann, Therese
    Reddy, K. Rajender
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (11) : 2389 - +
  • [27] Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era
    Cotter, Thomas G.
    Paul, Sonali
    Sandikci, Burhaneddin
    Couri, Thomas
    Bodzin, Adam S.
    Little, Ester C.
    Sundaram, Vinay
    Charlton, Michael
    LIVER TRANSPLANTATION, 2019, 25 (04) : 598 - 609
  • [28] Direct-Acting Antiviral Therapy Immune-Mediated Graft Dysfunction in Liver Transplant Recipients with Hepatitis C
    Chan, C.
    Agudelo, E.
    Haydek, J.
    Hoteit, M.
    Laurito, M.
    Norvell, J.
    Schiano, T.
    Terrault, N.
    Verna, E.
    Yang, A.
    Levitsky, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 345 - 346
  • [29] Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
    Fiehn, Felix
    Beisel, Claudia
    Binder, Marco
    CURRENT OPINION IN VIROLOGY, 2024, 67
  • [30] Rates of liver retransplantation in the United States are declining in the era of direct-acting antiviral agents
    Cholankeril, G.
    Yoo, E. R.
    Hu, M.
    Gadiparthi, C.
    Khan, M. A.
    Perumpail, R. B.
    Bonham, C. A.
    Ahmed, A.
    JOURNAL OF VIRAL HEPATITIS, 2017, 24 (12) : 1194 - 1195
12345